Deferoxamine mesylate (HY-B0988, MCE) was dissolved properly, and was given by daily intraperitoneal (i.p) injection at the different doses, including 25 mg/kg/day, 50 mg/kg/day, and 100 mg/kg/day.
Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients
(2) Imatinib is a drug used for certain types of cancer and is marketed as its mesylate salt. It is a tyrosine kinase inhibitor and one of the first molecularly targeted therapies used in clinical ...
In 1963, Ciba introduced a breakthrough product for the treatment of iron and alumium overload called Desferal (chelating agent-deferrioxamine methanesulphonate). In 1929, Sandoz introduced a ...
Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates ...
Pritelivir mesylate is under clinical development by AiCuris Anti-infective Cures and currently in Phase III for Simplexvirus (HSV) Infections. According to GlobalData, Phase III drugs for ...
Mitochondrial dysfunction is involved in numerous diseases and the aging process. The integrated stress response (ISR) serves as a critical adaptation mechanism to a variety of stresses, including ...
Traumatic brain injury (TBI) is one of the most harmful forms of acute brain injury and predicted to be one of the three major neurological diseases that cause neurological disabilities by 2030. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback